Search or

𝛼SK

ENTITY

Oncolys Biopharma (4588 JP)

1

Analysis

Health Care • Japan

Oncolys BioPharma Inc. provides pharmaceutical and diagnostic products and services.. The Company researches, develops, manufactures and sells drugs targeting cancer and serious infectious diseases and also provides inspection services for viruses.

more

Refresh

Exchange Announcement • 07 Nov 2025 14:30

Non-Consolidated Financial Results For The Nine Months Ended September 30, 2025 [Japanese Gaap]

Exchange Announcement • 08 Aug 2025 13:00

Non-Consolidated Financial Results For The Six Months Ended June 30, 2025 [Japanese Gaap]

Exchange Announcement • 09 May 2025 14:30

Non-Consolidated Financial Results For The Three Months Ended March 31, 2025 [Japanese Gaap]

Exchange Announcement • 07 Feb 2025 15:00

Non-Consolidated Financial Results For The Fiscal Year Ended December 31, 2024 [Japanese Gaap]

Exchange Announcement • 27 Jan 2025 11:15

(Delayed) Announcement Of Final Safety And Clinical Complete Response Data Presentation Of Phase I Clinical Trial For Obp-301-Crt At Asco Gi 2025

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x